Article
The effects of Natalizumab Treatment on Astrocyte Metabolism in Multiple Sclerosis: A Longitudinal <sup>11</sup> C-acetate PET study
2026-06-01
Abstract excerpt
<h4>Objective: </h4> Astrocyte activation is increasingly recognized as an important component of multiple sclerosis (MS) pathology. Natalizumab (NTZ), a highly effective therapy for relapsing-remitting MS (RRMS), primarily blocks leukocyte trafficking into the central nervous system. However, its effects on astrocytic metabolism remain unclear. We investigated astrocyte-associated metabolic changes after NTZ trea...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e9b81c61-7011-5039-b52d-e070b5ef1cce
- DOI
- 10.64898/2026.05.22.26353552
